Given that P. acnes causes inflammation in acne and that AMPs such as hBD-2, LL-37, S100A7, and RNase 7 show killing activity against P. acnes and inhibit inflammatory reactions mediated by bacterial products, these molecules are potential candidates for the prevention and treatment of acne vulgaris. This evidence concerns the gene ADSL and acne.